Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

History of Hepatitis B Infection Is the Most Common Risk Factor Impacting Eligibility in Minority Donors for Cord Blood

Rodica Ciubotariu, MD PhD, Michal J Tarnawski, MD, Ludy Dobrila, PhD, Maria S Albano, PhD, Andromachi Scaradavou, MD, Pablo Rubinstein, MD

Blood (2014) 124 (21): 2453.

https://doi.org/10.1182/blood.V124.21.2453.2453

Published: 2014

Journal Articles

A highly specific blood test for vCJD

Graham S. Jackson, Jesse Burk-Rafel, Julie A. Edgeworth, Anita Sicilia, Sabah Abdilahi, Justine Korteweg, Jonathan Mackey, Claire Thomas, Guosu Wang, Simon Mead, John Collinge

Blood (2014) 123 (3): 452–453.

https://doi.org/10.1182/blood-2013-11-539239

Published: 2014

Journal Articles

Phase 1 Clinical Trial of Prion-Filtered Red Cell Concentrates (pfRCC) in Patients Requiring Allogeneic Blood Transfusion.

Tracy Murphy, Mary R Cahill, Jim Fagan, Croxon Harry, Mohammed Khan, Oonagh Gilligan, Stephen McGrath, William G Murphy

Blood (2008) 112 (11): 994.

https://doi.org/10.1182/blood.V112.11.994.994

Published: 2008

Journal Articles

Efficient Reduction of Prions by the Manufacturing Process of a VWF/FVIII Product

Albrecht Groener, Martin Groschup, Wolfram Schäfer

Blood (2008) 112 (11): 995.

https://doi.org/10.1182/blood.V112.11.995.995

Published: 2008

Journal Articles

Normal prion protein trafficking in cultured human erythroblasts

Rebecca E. Griffiths, Kate J. Heesom, David J. Anstee

Blood (2007) 110 (13): 4518–4525.

https://doi.org/10.1182/blood-2007-04-085183

Published: 2007

Journal Articles

Successful Use of Recombinant Factor IX Concentrate (Nonacog-alfa, Benefix®) in Two Patients with Severe Hemophilia B and Total Knee Replacement (TKR).

Andrea Gerhardt, MD, Kristina Stahlschmidt, MD, Ansgar Ilg, MD, Rudiger E. Scharf, MD, Rainer B. Zotz, MD

Blood (2007) 110 (11): 3947.

https://doi.org/10.1182/blood.V110.11.3947.3947

Published: 2007

Journal Articles

Reduction of Prion Infectivity in Packed Red Cells by Separation of Whole Blood and Washing of the Red Cell Fraction.

Rodrigo Morales, BSc, Kimberley A. Buytaert-Hoefen, Ph.D., Eric T. Hansen, M.S., Dennis Hlavinka, M.S, Raymond Goodrich, Ph.D., Claudio Soto, Ph.D.

Blood (2007) 110 (11): 2890.

https://doi.org/10.1182/blood.V110.11.2890.2890

Published: 2007

Journal Articles

Measures Taken for Effective Virus Reduction of Plasma-Derived Coagulation Factor Concentrates.

Albrecht Groener, Thomas Nowak, Wolfram Schäfer

Blood (2006) 108 (11): 4009.

https://doi.org/10.1182/blood.V108.11.4009.4009

Published: 2006

Journal Articles

The Post-Transfusion Recovery and Survival of Red Blood Cells in Mice Is Affected by the Expression of Cellular Prion Protein.

Karel Holada, PhD, Jan Simak, PhD, Jaroslav G. Vostal, MD, PhD

Blood (2006) 108 (11): 959.

https://doi.org/10.1182/blood.V108.11.959.959

Published: 2006

Journal Articles

Expression of Cellular Prion Protein (PrPc) on Human Red Blood Cells.

Martin Panigaj, MS, Adela Brouckova, MS, Hana Glierova, MS, Karel Holada, PhD

Blood (2005) 106 (11): 1898.

https://doi.org/10.1182/blood.V106.11.1898.1898

Published: 2005

Journal Articles

Removal of Prions by the Manufacturing Process of Haemate ® P/Humate-P ® .

Albrecht Groener, Wolfram Schäfer, Martin Vey

Blood (2005) 106 (11): 4171.

https://doi.org/10.1182/blood.V106.11.4171.4171

Published: 2005

Journal Articles

Solvent-Detergent Treatment and Ion-Exchange Chromatography Have No Impact on Prion Removal by 15 nm Nanofiltration in the Manufacture of Factane ® .

Pierre Porte, Jean-Thierry Aubin, Samuel Arrabal, Christine Kimmel-Jehan, Sami Chtourou, Benoit Flan

Blood (2005) 106 (11): 4177.

https://doi.org/10.1182/blood.V106.11.4177.4177

Published: 2005

Journal Articles

Efficacy of Aprotinin in Reducing Blood Loss in Paediatric Patients Undergoing Major Spinal Surgery.

Hayley M. Greenfield, MRCP, Vesna Colovic, MRCP, Maged I. Gharib, MRCPath, Sarah Rushman, MRCP, Davendra K. Patel, MRCP, Andrew M. Will, FRCP, Robert W.M. Walker, MRCP

Blood (2004) 104 (11): 2716.

https://doi.org/10.1182/blood.V104.11.2716.2716

Published: 2004

Journal Articles

Immunohistochemical Analysis of Cellular Prion Protein Expression on Vascular Endothelial Cells.

Muttuswamy Sivakumaran, MSc, FRCP, FRCPath, PhD, Christine Frost, FIBMS

Blood (2004) 104 (11): 2725.

https://doi.org/10.1182/blood.V104.11.2725.2725

Published: 2004

Journal Articles

Sanitization of Equipment and Material Used in the Production of Plasma Derivatives by Standard Procedures Results in Removal and Inactivation of Prions.

Albrecht Groener, Waltraud Seyfert-Brandt, Wolfram Schäfer

Blood (2004) 104 (11): 3641.

https://doi.org/10.1182/blood.V104.11.3641.3641

Published: 2004

Journal Articles

Hamster Prions Are a Suitable Model for Partitioning of Human CJD Prions during Plasma Processing Steps.

Albrecht Groener, Wolfram Schäfer, Henry Baron, Martin Vey

Blood (2004) 104 (11): 3644.

https://doi.org/10.1182/blood.V104.11.3644.3644

Published: 2004

NARROW

History of Hepatitis B Infection Is the Most Common Risk Factor Impacting Eligibility in Minority Donors for Cord Blood

A highly specific blood test for vCJD

Phase 1 Clinical Trial of Prion-Filtered Red Cell Concentrates (pfRCC) in Patients Requiring Allogeneic Blood Transfusion.

Efficient Reduction of Prions by the Manufacturing Process of a VWF/FVIII Product

Normal prion protein trafficking in cultured human erythroblasts

Successful Use of Recombinant Factor IX Concentrate (Nonacog-alfa, Benefix®) in Two Patients with Severe Hemophilia B and Total Knee Replacement (TKR).

Reduction of Prion Infectivity in Packed Red Cells by Separation of Whole Blood and Washing of the Red Cell Fraction.

Measures Taken for Effective Virus Reduction of Plasma-Derived Coagulation Factor Concentrates.

The Post-Transfusion Recovery and Survival of Red Blood Cells in Mice Is Affected by the Expression of Cellular Prion Protein.

Expression of Cellular Prion Protein (PrPc) on Human Red Blood Cells.

Removal of Prions by the Manufacturing Process of Haemate ® P/Humate-P ® .

Solvent-Detergent Treatment and Ion-Exchange Chromatography Have No Impact on Prion Removal by 15 nm Nanofiltration in the Manufacture of Factane ® .

Efficacy of Aprotinin in Reducing Blood Loss in Paediatric Patients Undergoing Major Spinal Surgery.

Immunohistochemical Analysis of Cellular Prion Protein Expression on Vascular Endothelial Cells.

Sanitization of Equipment and Material Used in the Production of Plasma Derivatives by Standard Procedures Results in Removal and Inactivation of Prions.

Hamster Prions Are a Suitable Model for Partitioning of Human CJD Prions during Plasma Processing Steps.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only